New York, NY — March 26, 2015 — Global Newswire — New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm represented Citius Pharmaceuticals, LLC (OTCQB: CTXR), a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets, in connection with a $270,000 PIPE transaction. The transaction consisted of 500,000 Units for a purchase price pf $0.60 per Unit, resulting in gross proceeds of $270,000 for the company. Each Unit sold consisted of one share of common stock and a five-year warrant. The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and Arthur S. Marcus.
Media Contact:
pr@srf.law
(212)-930-9700
- Sichenzia Ross Ference Carmel LLP Represents Sharps Technology in $400 Million Private Placement - August 28, 2025
- 美国思成律师事务所代表Dominari Securities、Pacific Century Securities和Revere Securities完成Curanex Pharmaceuticals纳斯达克上市 - August 27, 2025
- Sichenzia Ross Ference Carmel LLP Represents Dominari Securities in $15 Million Initial Public Offering of Curanex Pharmaceuticals - August 27, 2025